Translational Medicine Course Announcement

Course Directors:

David Chaplin, M.D., Ph.D.
This email address is being protected from spambots. You need JavaScript enabled to view it.

Lisa Schwiebert, Ph.D.
This email address is being protected from spambots. You need JavaScript enabled to view it.

Spring 2015

"Translational Medicine Course for M.D. and Ph.D. Postdoctoral Scholars"

Objective:


This course will introduce every aspect of preparing and conducting a clinical and translational science research program, including program design, data analysis, and regulatory requirements. It will be instructed by both physician-scientists and Ph.D. scientists. Class topics will include:

  • Design, implementation, and value of all phases of clinical and tranlational research
  • Interdisciplinary team science—how to get and to keep M.D.s and Ph.D.s working together
  • Importance of epidemiology, statistics and informatics to clinical and translational research
  • Regulatory and ethical concerns for human studies


Throughout the course, participants will be encouraged to design a pilot clinical and translational project using a team-based approach. All projects will be critiqued by participating faculty. This course is open to M.D. and Ph.D. postdoctoral scholars in all disciplines.

Class meeting Schedule
The class will take place next Spring 2015. 
Course enrollment is limited to 25 participants.
Please contact postdocs@uab to enroll.

UAB News

  • "We have a broader array of workers than you'd see in other cities, from hourly employees in mining and manufacturing to CEOs of biotech firms," says Jack Howard, Ph.D., associate dean at the University of Alabama at Birmingham's Collat School of Business. "It's a laid-back culture, but there's a very strong work ethic."

  • There are a lot of regimens being tried in transplant, and most include calcineurin inhibitors that have significant toxicity," Anupam Agarwal, MD, of the University of Alabama at Birmingham, told MedPage Today. "Hence, if one could safely reduce the dose of the calcineurin inhibitor and still benefit from its immunosuppressive properties, it would be huge advance."

UAB Research News

  • Shirey, who will be inducted in September, is nationally recognized for her innovative integration of teaching and learning strategies.Maria R. Shirey, Ph.D., professor and assistant dean for Clinical Affairs and Partnerships in the University of Alabama at Birmingham School of Nursing, has been selected for induction as a fellow into the National League for Nursing Academy of Nursing Education. Shirey is nationally recognized for her innovative integration of teaching and learning strategies using research, evidence-based practice...

  • The Quad Rider makes it easy to shift gears and brake, enabling people with poor grip-control to safely cycle.The University of Alabama at Birmingham and the Lakeshore Foundation are partnering with InvoTek, Inc., to create a gear and braking device that helps people with disabilities who have limited or no use of their hands operate a handcycle safely. InvoTek, a research and development company in Alma, Arkansas, has received a $175,000 Phase I Small Business Innovation...